4/A

OWNERSHIP DOCUMENT

Company: Nuvectis Pharma, Inc.
Filed: May 12, 2025
Period of Report: May 6, 2025
Accession Number: 0001104659-25-047089

View Document ↗ View on SEC.gov ↗